SE0300831D0 - New formulations and use therof - Google Patents

New formulations and use therof

Info

Publication number
SE0300831D0
SE0300831D0 SE0300831A SE0300831A SE0300831D0 SE 0300831 D0 SE0300831 D0 SE 0300831D0 SE 0300831 A SE0300831 A SE 0300831A SE 0300831 A SE0300831 A SE 0300831A SE 0300831 D0 SE0300831 D0 SE 0300831D0
Authority
SE
Sweden
Prior art keywords
new formulations
formulation
use therof
use
therof
Prior art date
Application number
SE0300831A
Other languages
Swedish (sv)
Inventor
Fredrik Nicklasson
Kristina Thyresson
Nils-Olof Lindberg
Alice C Martino
Kristina Lindell
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0300831A priority Critical patent/SE0300831D0/en
Publication of SE0300831D0 publication Critical patent/SE0300831D0/en
Priority claimed from US10/816,672 external-priority patent/US20040191298A1/en

Links

Abstract

A pharmaceutical formulation comprising one or more active pharmaceutical ingredients (APIs) suitable for intraoral uptake, that comprises cocoa powder, a process for manufacturing the formulation and use of the formulation for medical treatment.
SE0300831A 2003-03-26 2003-03-26 New formulations and use therof SE0300831D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE0300831A SE0300831D0 (en) 2003-03-26 2003-03-26 New formulations and use therof

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
SE0300831A SE0300831D0 (en) 2003-03-26 2003-03-26 New formulations and use therof
AU2004224557A AU2004224557B2 (en) 2003-03-26 2004-03-16 Formulations comprising an active ingredient and cocoa powder and use thereof
CA 2519155 CA2519155A1 (en) 2003-03-26 2004-03-16 Formulations comprising an active ingredient and cocoa powder and use thereof
EP04720946A EP1605921A1 (en) 2003-03-26 2004-03-16 Formulations comprising an active ingredient and cocoa powder and use thereof
PCT/IB2004/000860 WO2004084865A1 (en) 2003-03-26 2004-03-16 Formulations comprising an active ingredient and cocoa powder and use thereof
JP2006506377A JP2006521348A (en) 2003-03-26 2004-03-16 Formulations containing the active ingredient and cocoa powder, as well as their use
MXPA05010196A MXPA05010196A (en) 2003-03-26 2004-03-16 Formulations comprising an active ingredient and cocoa powder and use thereof.
BRPI0408655 BRPI0408655A (en) 2003-03-26 2004-03-16 formulations comprising an active agent and cocoa powder and its use
CN 200480007789 CN1764440A (en) 2003-03-26 2004-03-16 Formulations comprising an active ingredient and cocoa powder and use thereof
CL2004000564A CL2004000564A1 (en) 2003-03-26 2004-03-18 pharmaceutical formulation for oral administration comprising one or more pharmaceutically active agents and cocoa powder.
TW093107802A TW200503782A (en) 2003-03-26 2004-03-23 New formulations and use thereof
ARP040100981 AR043772A1 (en) 2003-03-26 2004-03-24 Formulations comprising an active ingredient and cocoa powder and use
US10/816,672 US20040191298A1 (en) 2003-03-26 2004-04-02 New formulations and use thereof
ZA200507719A ZA200507719B (en) 2003-03-26 2005-09-23 Formulations comprising an active ingredient and cocoa powder and use thereof
US12/143,001 US20080249143A1 (en) 2003-03-26 2008-06-20 New formulations and use thereof
US12/709,953 US20100197742A1 (en) 2003-03-26 2010-02-22 New formulations and use thereof
JP2010255113A JP2011079841A (en) 2003-03-26 2010-11-15 Formulation containing active ingredient and cacao powder, and use thereof

Publications (1)

Publication Number Publication Date
SE0300831D0 true SE0300831D0 (en) 2003-03-26

Family

ID=20290786

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300831A SE0300831D0 (en) 2003-03-26 2003-03-26 New formulations and use therof

Country Status (13)

Country Link
EP (1) EP1605921A1 (en)
JP (2) JP2006521348A (en)
CN (1) CN1764440A (en)
AR (1) AR043772A1 (en)
AU (1) AU2004224557B2 (en)
BR (1) BRPI0408655A (en)
CA (1) CA2519155A1 (en)
CL (1) CL2004000564A1 (en)
MX (1) MXPA05010196A (en)
SE (1) SE0300831D0 (en)
TW (1) TW200503782A (en)
WO (1) WO2004084865A1 (en)
ZA (1) ZA200507719B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU764453B2 (en) 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR100960200B1 (en) 2000-10-30 2010-05-27 유로-셀티크 소시에떼 아노뉨 Controlled release hydrocodone formulations
CN101237850A (en) * 2005-08-02 2008-08-06 德罗萨帕尔姆股份公司 Pharmaceutical composition containing indometacin and/or acemetacin
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
MX2009013580A (en) 2007-06-13 2010-01-20 Otsuka Pharma Co Ltd Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food.
CN101444273B (en) * 2007-11-22 2013-04-24 何煜 Health product oral fast-release preparation and production method thereof
WO2009070978A1 (en) * 2007-11-22 2009-06-11 Yu He An oral cavity rapid release of the health products and its preparation method
CN101439053A (en) * 2007-11-22 2009-05-27 煜 何 Chinese medicine rapid-release preparation for oral cavity and method for producing the same
CA2761538A1 (en) * 2009-05-20 2010-12-23 Lingual Consegna Pty Ltd Buccal and/or sublingual therapeutic formulation
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
JP2013526523A (en) 2010-05-11 2013-06-24 シマ ラブス インク. Alcohol resistant sustained release oral dosage form comprising metoprolol
EP2964243A1 (en) 2013-03-06 2016-01-13 Capsugel Belgium NV Curcumin solid lipid particles and methods for their preparation and use
CN103583781B (en) * 2013-11-01 2015-11-25 阳波 Coffee flavored chewing gum metronidazole
WO2015189726A1 (en) * 2014-06-10 2015-12-17 Capsugel Belgium Nv Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
JP6334482B2 (en) * 2015-08-28 2018-05-30 中野Bc株式会社 Solid agent and a method of manufacturing the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB785574A (en) * 1955-03-29 1957-10-30 Pfizer & Co C Pharmaceutical compositions containing tetracycline antibiotics
GB918955A (en) * 1960-05-19 1963-02-20 Thomae Gmbh Dr K Pharmaceutical laxative compositions comprising 4,4-dihydroxy-2-amino triphenylmethane
FR2717387B1 (en) * 1994-03-17 1996-10-18 Hi Pharmtech A process for manufacturing chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate and amoxicillin.
SE9803986D0 (en) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New Compositions
JP2001106641A (en) * 1999-10-06 2001-04-17 Tendou Seiyaku Kk Intraoral medicine
JP2001114668A (en) * 1999-10-13 2001-04-24 Meiji Seika Kaisha Ltd Chocolate preparation
JP2002193839A (en) * 2000-12-27 2002-07-10 Meiji Seika Kaisha Ltd Cocoa pharmaceutical preparation
SE0103211D0 (en) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof

Also Published As

Publication number Publication date
TW200503782A (en) 2005-02-01
MXPA05010196A (en) 2005-11-08
CN1764440A (en) 2006-04-26
AU2004224557A1 (en) 2004-10-07
JP2011079841A (en) 2011-04-21
BRPI0408655A (en) 2006-03-28
CA2519155A1 (en) 2004-10-07
JP2006521348A (en) 2006-09-21
CL2004000564A1 (en) 2005-02-04
AU2004224557B2 (en) 2009-06-18
EP1605921A1 (en) 2005-12-21
WO2004084865A1 (en) 2004-10-07
AR043772A1 (en) 2005-08-10
ZA200507719B (en) 2007-09-26

Similar Documents

Publication Publication Date Title
RU2227022C2 (en) Bioadhesive buccal sustained-release tablet
CA2307018C (en) Osmotic medicament releasing system
TW590778B (en) Pharmaceutical composition of topiramate
DE60022735D1 (en) Comprising imiquimod formulations or other immune response modifying compounds for the treatment of cervical dysplasia
IT1318539B1 (en) Pharmaceutical compositions for extended release parenteral lasomministrazione of hydrophilic substances biologically
DE50206657D1 (en) A pharmaceutical composition for the treatment of multiple sclerosis
DOP2008000001A (en) Oxazolidinone replaced and its use
SE0001899D0 (en) New compounds
EA200600696A1 (en) Pharmaceutical compositions for prevention of overdosage or improper use of medicines
CY1111726T1 (en) PHARMACEUTICAL COMPOSITIONS to treat ASTHMA
BR0207961A (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
NO20062504L (en) Compositions and dosage forms for improved absorption
NO335889B1 (en) New hydroxamates pharmaceutical composition comprising them and the use thereof for the manufacture of a medicament for the treatment of cancer
TR199901669T2 (en) Dosage forms and methods necessary for the treatment of male erectile dysfunction.
NO329386B1 (en) Glucocorticoids-mimetic, pharmaceutical compositions and uses for the preparation of medikamenterfor treating disease
NO20040331L (en) Medicines for diseases of bone mass loss that has Eragonist as the active ingredient
ITRM930591D0 (en) A medical device for the administration of active ingredients or in very low dosage drugs, particularly of homeopathic drugs.
MXPA03007712A (en) Pharmaceutical salts.
AT450259T (en) The oral dosage form containing a therapeutic agent and a drug will end against
MXPA03001332A (en) Quinazoline derivatives.
CA2451258C (en) Combination therapy of substituted oxazolidinones
KR977003151A (en) Oral liquid formulations of alendronate (alendronate Oral liquid formulations)
RU2000132713A (en) Formulations for administration of anti-inflammatory, especially antiseptic agents and / or agents promoting the healing of wounds in the lower respiratory tract
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
SE0301700D0 (en) Novel compounds